论文部分内容阅读
目的探讨糖尿病患者血糖控制在12 mmol/L以下,颞侧透明角膜切口白内障超声乳化及人工晶状体植入术的临床效果。方法对糖尿病白内障患者58例(72眼)施行颞侧透明角膜切口白内障超声乳化及人工晶状体植入术,观察手术并发症及术后视力、切口愈合情况。结果随访1年,裸眼或矫正视力≤0.1者2眼(2.78%),0.1~0.3者1眼(1.39%),0.3~0.5者2眼(2.78%),0.8~1.5者67眼(93.06%)。术中无出血,术后无感染,切口愈合良好。结论糖尿病白内障患者餐后血糖控制在12 mmol/L以下者,于表面麻醉下行白内障超声乳化及人工晶状体植入术是安全可行的。
Objective To investigate the clinical effect of blood glucose control in diabetic patients below 12 mmol / L, temporal corneal incision cataract phacoemulsification and intraocular lens implantation. Methods 58 patients (72 eyes) with diabetic cataract underwent temporal corneal incision cataract phacoemulsification and intraocular lens implantation. The complication, postoperative visual acuity and incision healing were observed. Results One year follow-up showed that there were 2 eyes (2.78%) with visual acuity ≤0.1, 1.39% with 0.1 ~ 0.3, 2.78% with 0.3 ~ 0.5, 67 eyes with 93% ). No bleeding during surgery, postoperative infection, incision healed well. Conclusions Postprandial blood glucose control in patients with cataract is below 12 mmol / L. It is safe and feasible to perform phacoemulsification and intraocular lens implantation under surface anesthesia.